Results 121 to 130 of about 21,115,427 (202)

Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2. [PDF]

Theranostics, 2021
Huang Y, Yu SH, Zhen WX, Cheng T, Wang D, Lin JB, Wu YH, Wang YF, Chen Y, Shu LP, Wang Y, Sun XJ, Zhou Y, Yang F, Hsu CH, Xu PF.   +15 more
europepmc   +1 more source

[Retracted] Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines. [PDF]

Mol Med Rep, 2021
Wang L, Wu J, Lu J, Ma R, Sun D, Tang J.
europepmc   +1 more source

Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles

, 2013
Yan-rong Jiang,1,2 Zhen-hai Zhang,1 Qi-yuan Liu,1,2 Shao-ying Hu,1,2 Xiao-yun Chen,1,2 Xiao-bin Jia11Key Laboratory of New Drug Delivery System of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine, Nanjing, Jiangsu, People’s ...
Jia XB, Hu SY, Jiang YR, Zhang ZH, Chen XY, Liu QY   +5 more
core  

Tanshinone I inhibited growth of human chronic myeloid leukemia cells via JNK/ERK mediated apoptotic pathways. [PDF]

Braz J Med Biol Res, 2021
Sun S, Zhu L, Lai M, Cheng R, Ge Y.
europepmc   +1 more source

Tanshinone I exerts cardiovascular protective effects in vivo and in vitro through inhibiting necroptosis via Akt/Nrf2 signaling pathway. [PDF]

Chin Med, 2021
Zhuo Y, Yuan R, Chen X, He J, Chen Y, Zhang C, Sun K, Yang S, Liu Z, Gao H.   +9 more
europepmc   +1 more source

Tanshinone IIA Promoted Autophagy and Inhibited Inflammation to Alleviate Podocyte Injury in Diabetic Nephropathy [PDF]

Yuan Li,1 Tong Wu,1 Hongye Li,2 Mingming Liu,2 Haiyan Xu1 1School of Basic Medicine, Xuzhou Medical University, Xuzhou, 221004, People’s Republic of China; 2Lianyungang Clinical School of Xuzhou Medical University, Lianyungang, 222006, People’s Republic ...
Li H, Li Y, Liu M, Wu T, Xu H
core  

갑상선안병증 in vitro 모델에서 tanshinone IIA의 치료적 역할

, 2013
Dept. of Medicine/박사갑상선안병증은 아직까지 그 발생기전이 명확하지는 않으나, 전형적인 자가면역 염증질환으로, 안와섬유모세포의 급성 염증반응, hyaluronan 생성 및 지방분화의 증가로 인한 안와내 지방결체조직과 외안근의 팽창이 주요 기전으로 생각되고 있다. 고용량 스테로이드와 방사선치료가 활동성 염증기의 갑상선안병증에는 진행억제 효과가 있지만 비활동성, 만성염증 시기에는 효과가 없으며, 부작용으로 인해 사용에 한계가 있다.
유수리나
core  

Targeting RSF1 with tanshinone I inhibits cervical cancer cell growth through modulation of NF-κB pathway. [PDF]

Front Pharmacol
Shen Y, Lu S, Zhao Q, Cui T, Cui H, Cui Z, Shan L, Guo C, Shi L.   +8 more
europepmc   +1 more source

丹参酮IIA在人肝微粒体中的代谢研究

, 2009
Salvia miltiorrhiza (Danshen) has been widely used in China for the treatment of coronary heart disease, cerebrovascular disease, bone loss, hepatitis, hepatocirrhosis and chronic renal failure.
杨凌, 刘慧鑫
core  

Regulatory Effect and Mechanism of Tanshinone I on Cell Apoptosis in Steroid-Induced Osteonecrosis of the Femoral Head. [PDF]

Kaohsiung J Med Sci
Su Q, Chen J.
europepmc   +1 more source